Recursion (RXRX) stock dips after $200M equity offering despite Sanofi (SNY) choosing its first AI drug candidate under a ...

MONTREAL — The next advances in the capabilities of AI could well be made by AI itself, as tech giants and startups automate more machine learning research and development. Many firms are aiming for ...

This is the fifth installment of the mathematics series. In the first article, “Fermat Test — Another Principle of Primality ...

Researchers from the National University of Singapore, A*STAR, and the Australian National University have demonstrated a ...

Researchers have replaced trial-and-error tuning of a recursive least squares identifier with a hill-climbing algorithm and a ...

We introduce Multi-Agent Self-Supervision (MASS). One shared model solves tasks through a team of virtual subagents, searches for better multi-agent workflows, then uses its own judgments to select ...

A new special issue of AI & Society, framed by N. Katherine Hayles, maps the mutual entanglement of humans and algorithms, ...

OpenSSH 10.6 disables LZ77 compression, refuses some usernames and plans more frequent releases after AI-found bugs resurfaced.

Seller: Robert Hershberg, Director at Recursion Pharmaceuticals, Inc. Shares for sale: 25,000 Class A shares valued at ...

According to KyeGomezB, P Zero Research reports AI research taste doubled every 3 months since Dec 2025, surpassing expert baseline.

Tempus AI Inc. stocks have been trading up by 6.55 percent after bullish coverage on its AI-driven healthcare data platform.

Richard Socher, co-founder and CEO of Recursive, argues on the Peter Diamandis podcast that while weak forms of recursive self-improvement ...